Armando Anido's Net Worth
$12.1 Million
Who is Armando Anido?
Armando Anido has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include NUPATHE INC., Biota Pharmaceuticals, Inc., SCYNEXIS INC, Zynerba Pharmaceuticals, Inc., AUXILIUM PHARMACEUTICALS INC, ADOLOR CORP, and MEDIMMUNE INC /DE.
SEC CIK
Armando Anido's CIK is 0001219866
Past Insider Trading and Trends
2011 was Armando Anido's most active year for acquiring shares with 17 total transactions. Armando Anido's most active month to acquire stocks was the month of December. 2011 was Armando Anido's most active year for disposing of shares, totalling 21 transactions. Armando Anido's most active month to dispose stocks was the month of February. 2006 saw Armando Anido paying a total of $1,838,303.54 for 726,562 shares, this is the most they've acquired in one year. In 2014 Armando Anido cashed out on 1,270,000 shares for a total of $8,636,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NUPATHE INC. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.27M |
$6.80 | -$8,636,000.00 |
0
|
Feb 21
| |||
Form 4
| +33.34% | 317.58K |
—
|
—
| 1.27M |
Jan 17
| |||
Form 4
| +63.27% | 369.1K |
—
|
—
| 952.42K |
Jan 7
| |||
Form 4
|
∞
| 583.33K |
—
|
—
| 583.33K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aviragen Therapeutics, Inc. (VXRT) Snapshot price: $0.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
| No matching records found | |||||||||
SCYNEXIS INC (SCYX) Snapshot price: $1.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +92.00% | 23K |
—
|
—
| 48K |
Jun 20
| |||
Form 4
| +66.67% | 10K |
—
|
—
| 25K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +200.00% | 10K |
—
|
—
| 15K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
∞
| 5K |
$6.25 | $31,250.00 | 5K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zynerba Pharmaceuticals, Inc. No price found
Chairman & Chief Exec. Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -976.61K |
—
|
—
|
0
|
Oct 10
| |||
Form 4
| +5.27% | 46.92K |
$1.33 | -$23,637.23 | 936.72K |
Sep 12 - Sep 13
| |||
Form 4
| +3.83% | 32.86K |
$0.60 | -$7,484.29 | 889.8K |
Feb 7 - Feb 8
| |||
Form 4
| +3.72% | 30.71K |
$0.60 | -$6,979.32 | 856.95K |
Jan 31 - Feb 1
| |||
Form 4
| +35.07% | 214.55K |
$0.60 | -$21,193.80 | 826.24K |
Jan 23 - Jan 24
| |||
Form 4
| +5.39% | 31.27K |
$1.10 | -$13,088.90 | 611.69K |
Jul 18 - Jul 19
| |||
Form 4
| +26.06% | 120K |
—
|
—
| 580.42K |
Jan 26
| |||
Form 4
| +30.61% | 107.91K |
—
|
—
| 460.42K |
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
| +4.44% | 15K |
$5.96 | $89,422.50 | 352.51K |
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
| +1.50% | 5K |
$19.70 | $98,515.00 | 337.51K |
May 12 - May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
∞
| 39.89K |
—
|
—
| 13.3K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AUXILIUM PHARMACEUTICALS INC No price found
CEO & President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$11.02 | -$33,848.09 | 13.65K |
Scheduled
|
Oct 7
| ||
Form 4
|
—
|
0
|
$14.06 | -$65,903.21 | 13.65K |
Scheduled
|
Jul 8
| ||
Form 4/A
| -15.05% | -2.42K |
$15.37 | -$214,913.84 | 13.65K |
Scheduled
|
Feb 28 - Mar 8
| ||
Form 4
|
—
|
0
|
$15.42 | -$160,558.91 | 16.07K |
Scheduled
|
Mar 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
$15.51 | -$162,615.89 | 16.07K |
Scheduled
|
Jan 10
| ||
Form 4
|
—
|
0
|
—
|
—
| 69.61K |
Jul 29
| |||
Form 4
| -31.55% | -32.08K |
$22.22 | -$712,817.60 | 69.61K |
Jul 17
| |||
Form 4
|
—
|
0
|
$20.44 | -$757,815.00 | 101.69K |
Scheduled
|
Apr 12
| ||
Form 4
| -2.32% | -2.42K |
$30.20 | -$73,053.80 | 101.69K |
Mar 12
| |||
Form 4
| +30.14% | 24.11K |
—
|
—
| 104.11K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
| 159.95K |
Sep 11
| |||
Form 4
| -12.92% | -16.03K |
$30.00 | -$480,960.00 | 108.02K |
Jul 17
| |||
Form 4
|
—
|
0
|
$19.06 | -$674,598.00 | 124.05K |
Scheduled
|
Jun 26
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
$18.77 | -$657,678.00 | 124.05K |
Scheduled
|
Mar 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +3.38% | 4.05K |
$30.00 | -$58,380.00 | 124.05K |
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
| 171.92K |
Sep 10
| |||
Form 4
| -8.53% | -16.03K |
$37.17 | -$595,909.44 | 171.92K |
Jul 17
| |||
Form 4
| -6.02% | -12.04K |
$16.25 | -$195,715.00 | 187.96K |
Jul 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 200K |
$7.81 | $1,562,000.00 | 200K |
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||